Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker completed the acquisition of Amplitude Vascular Systems, a privately held company focused on next-generation intravascular lithotripsy (IVL) technology for treating complex peripheral arterial disease. The deal adds AVS's CO₂-generated pressure wave technology to Stryker's peripheral vascular portfolio, enhancing its ability to address challenging arterial disease.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.